Nakai, C.; Miwa, K.; Kitagawa, Y.; Kikuchi, M.; Namiki, S.; Kikuchi, M.; Kawase, K.; Iinuma, K.; Tobisawa, Y.; Nakane, K.;
et al. The Efficacy of Intradetrusor Onabotulinumtoxin A Injection for Refractory Overactive Bladder Syndrome—A Single-Center Prospective Study. J. Clin. Med. 2025, 14, 4151.
https://doi.org/10.3390/jcm14124151
AMA Style
Nakai C, Miwa K, Kitagawa Y, Kikuchi M, Namiki S, Kikuchi M, Kawase K, Iinuma K, Tobisawa Y, Nakane K,
et al. The Efficacy of Intradetrusor Onabotulinumtoxin A Injection for Refractory Overactive Bladder Syndrome—A Single-Center Prospective Study. Journal of Clinical Medicine. 2025; 14(12):4151.
https://doi.org/10.3390/jcm14124151
Chicago/Turabian Style
Nakai, Chie, Kosei Miwa, Yasuhide Kitagawa, Moemi Kikuchi, Sanae Namiki, Mina Kikuchi, Kota Kawase, Koji Iinuma, Yuki Tobisawa, Keita Nakane,
and et al. 2025. "The Efficacy of Intradetrusor Onabotulinumtoxin A Injection for Refractory Overactive Bladder Syndrome—A Single-Center Prospective Study" Journal of Clinical Medicine 14, no. 12: 4151.
https://doi.org/10.3390/jcm14124151
APA Style
Nakai, C., Miwa, K., Kitagawa, Y., Kikuchi, M., Namiki, S., Kikuchi, M., Kawase, K., Iinuma, K., Tobisawa, Y., Nakane, K., & Koie, T.
(2025). The Efficacy of Intradetrusor Onabotulinumtoxin A Injection for Refractory Overactive Bladder Syndrome—A Single-Center Prospective Study. Journal of Clinical Medicine, 14(12), 4151.
https://doi.org/10.3390/jcm14124151
